These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

897 related items for PubMed ID: 28784659

  • 1. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S, Gärtner A, Kniss A, Stengl A, Behrends C, Rogov VV, Rodriguez MS, Dötsch V, Müller S, Ernst A.
    J Biol Chem; 2017 Sep 15; 292(37):15340-15351. PubMed ID: 28784659
    [Abstract] [Full Text] [Related]

  • 2. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K, Park H, Pandey N, Azuma Y, De Guzman RN.
    J Biol Chem; 2017 Jun 16; 292(24):10230-10238. PubMed ID: 28455449
    [Abstract] [Full Text] [Related]

  • 3. Dynamin interacts with members of the sumoylation machinery.
    Mishra RK, Jatiani SS, Kumar A, Simhadri VR, Hosur RV, Mittal R.
    J Biol Chem; 2004 Jul 23; 279(30):31445-54. PubMed ID: 15123615
    [Abstract] [Full Text] [Related]

  • 4. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
    Sha Z, Blyszcz T, González-Prieto R, Vertegaal ACO, Goldberg AL.
    J Biol Chem; 2019 Oct 18; 294(42):15218-15234. PubMed ID: 31285264
    [Abstract] [Full Text] [Related]

  • 5. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH, Lussier-Price M, Cappadocia L, Estephan P, Raiola L, Omichinski JG, Aubry M.
    J Biol Chem; 2013 Dec 20; 288(51):36312-27. PubMed ID: 24174529
    [Abstract] [Full Text] [Related]

  • 6. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
    Kim ET, Kim KK, Matunis MJ, Ahn JH.
    Biochem Biophys Res Commun; 2009 Oct 09; 388(1):41-5. PubMed ID: 19635459
    [Abstract] [Full Text] [Related]

  • 7. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
    Niedenthal R.
    Methods Mol Biol; 2009 Oct 09; 497():63-79. PubMed ID: 19107411
    [Abstract] [Full Text] [Related]

  • 8. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH, Kim S, Yu B, Jaffray E, Song J, Zheng J, Rodriguez MS, Hay RT, Chen Y.
    Biochemistry; 2003 Aug 26; 42(33):9959-69. PubMed ID: 12924945
    [Abstract] [Full Text] [Related]

  • 9. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â, Souza EE, Costa FC, Meirelles GV, Gonçalves KA, Santos MT, Bressan GC, McComb ME, Costello CE, Whelan SA, Kobarg J.
    J Proteome Res; 2017 Sep 01; 16(9):3147-3157. PubMed ID: 28695742
    [Abstract] [Full Text] [Related]

  • 10. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH, Kim S, Jaffray E, Song J, Chen Y, Hay RT.
    Nat Struct Mol Biol; 2005 Jan 01; 12(1):67-74. PubMed ID: 15608651
    [Abstract] [Full Text] [Related]

  • 11. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.
    McManus FP, Bourdeau V, Acevedo M, Lopes-Paciencia S, Mignacca L, Lamoliatte F, Rojas Pino JW, Ferbeyre G, Thibault P.
    Sci Rep; 2018 May 17; 8(1):7754. PubMed ID: 29773808
    [Abstract] [Full Text] [Related]

  • 12. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC, Lee CC, Yao YL, Lai CC, Schmitz ML, Yang WM.
    Sci Rep; 2016 May 23; 6():26509. PubMed ID: 27211601
    [Abstract] [Full Text] [Related]

  • 13. DNA repair and global sumoylation are regulated by distinct Ubc9 noncovalent complexes.
    Prudden J, Perry JJ, Nie M, Vashisht AA, Arvai AS, Hitomi C, Guenther G, Wohlschlegel JA, Tainer JA, Boddy MN.
    Mol Cell Biol; 2011 Jun 23; 31(11):2299-310. PubMed ID: 21444718
    [Abstract] [Full Text] [Related]

  • 14. The important roles of protein SUMOylation in the occurrence and development of leukemia and clinical implications.
    Zhao B, Zhang Z, Chen X, Shen Y, Qin Y, Yang X, Xing Z, Zhang S, Long X, Zhang Y, An S, Wu H, Qi Y.
    J Cell Physiol; 2021 May 23; 236(5):3466-3480. PubMed ID: 33151565
    [Abstract] [Full Text] [Related]

  • 15. Ubc9 sumoylation regulates SUMO target discrimination.
    Knipscheer P, Flotho A, Klug H, Olsen JV, van Dijk WJ, Fish A, Johnson ES, Mann M, Sixma TK, Pichler A.
    Mol Cell; 2008 Aug 08; 31(3):371-82. PubMed ID: 18691969
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
    Ding H, Xu Y, Chen Q, Dai H, Tang Y, Wu J, Shi Y.
    Biochemistry; 2005 Mar 01; 44(8):2790-9. PubMed ID: 15723523
    [Abstract] [Full Text] [Related]

  • 19. Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45.
    Sekiyama N, Arita K, Ikeda Y, Hashiguchi K, Ariyoshi M, Tochio H, Saitoh H, Shirakawa M.
    Proteins; 2010 May 01; 78(6):1491-502. PubMed ID: 20077568
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the interactions of HIV-1 integrase with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
    Li Z, Wu S, Wang J, Li W, Lin Y, Ji C, Xue J, Chen J.
    Int J Mol Med; 2012 Nov 01; 30(5):1053-60. PubMed ID: 22895527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.